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Multiple myeloma (mm) is an aggressive haematological malignancy arising from the monoclonal expansion of neoplastic plasma 
cells in the bone marrow.1–3 It tends to occur mostly 
in older patients, with men being twice as likely 
to be affected.2,3 MM usually occurs as a result of 
the progression from earlier conditions known 
as monoclonal gammopathy of undetermined 
significance (MGUS) and smouldering myeloma.2 
It can also evolve from a more localised form of 
the disease, referred to as solitary plasmacytoma 
(either bony or soft tissue); tissue samples from both 
localised plasmacytomas and MMs provide identical 
histopathological pictures.2–4
MM is usually restricted to the bone marrow 
and may present clinically with a range of complex 
manifestations, including anaemia, bone pain due 
to generalised osteoporosis or focal lytic lesions 
secondary to osteolytic bone destructions, hypercal-
caemia, renal dysfunction and a compromised 
immune system.5,6 Malignant plasma cells can escape 
the bone marrow microenvironment and proliferate 
at extramedullary sites; various sites such as the eyes, 
respiratory tract, testes, adrenal and thyroid glands, 
lymph nodes, skin and subcutaneous tissues, central 
nervous system and other organs have been reported 
in the literature.5–7 Extramedullary MM (EMM) can 
occur as a primary presentation or, more commonly, 
in a secondary form during progression or relapse 
of MM.6 The incidence of EMM ranges between 
2–20%.6,7 However, the occurrence of EMM in the 
oral and maxillofacial region is rare and infrequently 
reported, with varying degrees of symptoms including 
pain, swelling, bleeding, mobility of the teeth and 
nerve neuropathies.1,3,4 
Case Report 
A 56-year-old female patient was referred from the 
Haematology Department to the Oral & Maxillofacial 
Surgery Unit of Sultan Qaboos University Hospital, 
Muscat, Oman, in 2010 due to sudden-onset numb-
ness of the lower lip. The patient had first noticed the 
numbness 10 days previously. In 2008, the patient had 
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abstract: Multiple myeloma (MM) is an uncommon malignancy characterised by the proliferation of clonal 
plasma cells. There are few published reports describing the extramedullary presentation of MM manifesting 
primarily in the head and neck region. In addition, the occurrence of an isolated relapse of MM in these sites is 
exceedingly rare. We report a 56-year-old female who presented to the Sultan Qaboos University Hospital, Muscat, 
Oman, in 2010 with sudden-onset numbness of the lower lip. She had a history of MM in remission following 
chemotherapy and a bone marrow transplant. Clinical and radiographic examinations were indicative of a possible 
relapse of MM, which was subsequently confirmed by bone marrow aspiration and histopathological evaluation. 
This unique case highlights the unusual site of relapse of a haematolymphoid malignancy.
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امللخ�ص: الورم النقوي املتعدد هو ورم خبيث ن�در احلدوث ويتميز ب�إنت�ش�ر اخلالي� البالزمية. هن�ك بع�س التق�رير املن�شورة ت�شف حدوث 
الورم النقوي املتعدد خ�رج النخ�ع بظهور اأويل يف منطقة الراأ�س والعنق. ب�لإ�ش�فة اإىل ذلك, حدوث انتك��شة متفردة من الورم النقوي 
56 ع�م� تقدمت اإىل م�شت�شفى ج�معة ال�شلط�ن  املتعدد يف هذه املن�طق هو ن�در جدا. يعر�س هذا التقرير ح�لة مري�شة تبلغ من العمر 
ق�بو�س, م�شقط, �شلطنة عم�ن يف 2010 وهي م�ش�بة ب�خدرار مف�جئ يف ال�شفة ال�شفلية. وك�نت املري�شة م�ش�بة بورم نقوي متعدد يف 
مرحلة الهداة بعد املع�جلة الكيمي�ئية وزراعة نقي العظم. الفحو�ش�ت ال�رسيرية والإ�شع�عية التي اأجريت ك�نت تدل على اإحتم�لية وجود 
انتك��شة للورم النقوي املتعدد, وهو م� مت ت�أكيده لحق� عن طريق خزعة �شفط نقي العظم و تقييم مر�شي�ت الأن�شجة. هذه احل�لة الفريدة 
ت�شلط ال�شوء على اإمك�نية حدوث انتك��ش�ت لالأورام اللمف�وية اخلبيثة يف من�طق غري معت�دة.
الكلمات املفتاحية: الورم النقوي املتعدد؛ انتك��شة؛ اأورام الراأ�س والعنق؛ ورم البالزم�وي�ت؛ تقرير ح�لة؛ عم�ن.
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been diagnosed with immunoglobulin A-λ MM, after 
presenting with anaemia, hypercalcaemia, acute renal 
insufficiency and a compression fracture of the T12 
vertebra. Her initial symptoms included pain related 
to the long bones and back. She went into complete 
remission after being treated with bortezomib, dexa-
methasone and high-dose melphalan followed by an 
autologous stem cell transplantation in 2009. Post-
transplant, she remained in complete remission and 
was prescribed maintenance thalidomide therapy.
At referral, the patient was not in any pain and a 
comprehensive dental examination indicated a good 
oral status with multiple heavily restored teeth. No 
evidence of infection or dental pathology was noted. 
The numbness affected the left side of the lower 
lip, chin and gingivae of the 32nd to 36th teeth. An 
orthopantomogram and a computed tomography scan 
showed no evidence of dental or maxillofacial pathol-
ogy. Based on the clinical presentation, examination 
and the patient’s medical status, the possibility of a 
relapse of MM was strongly suspected. An urgent 
magnetic resonance imaging (MRI) examination of the 
mandible showed an enhancing soft tissue mass in the 
medial aspect of the left mandibular ramus extending 
to the bone marrow through the mandibular canal and 
a soft tissue enhancement near the left mental nerve at 
the opening of the mental foramen [Figure 1].
A bone marrow aspiration revealed the presence 
of over 24% plasma cells. A biopsy of the oral cavity 
lesion showed sheets of plasma cells with plasmablastic 
morphology and a cellular submucosal infiltrate of the 
neoplastic plasma cells. The cells were positive for 
cluster of differentiation (CD) 138 and negative for 
CD20, CD79a and Epstein-Barr virus, thus excluding a 
diagnosis of plasmablastic lymphoma. The aggressive 
nature of the proliferation was supported by the 
presence of frequent mitosis and a Ki67 proliferation 
index of >90% [Figure 2]. In combination, these find-
ings confirmed the diagnosis of a relapse of MM both 
in the bone marrow as well as at extramedullary sites, 
as indicated by the numbness of the left mental nerve 
and the soft tissue mass in the left retromolar area. 
Both the morphological and immunophenotypical 
features of the oral lesion and bone marrow aspirate 
histopathology specimens indicated that the relapse 
was a more aggressive form of the disease. 
Over the course of the following weeks, the 
retromolar mass continued to enlarge and became 
erythematous and ulcerated [Figure 3]. The patient 
received lenalidomide and dexamethasone but 
showed no response to treatment. She was sub-
sequently prescribed a bortezomib-based regimen. 
However, her condition continued to worsen and she 
developed multiple infections and extramedullary 
lesions in the shoulder and lungs. The patient died 
eight months after the diagnosis of a relapse of MM. 
 
Figure 1: Axial T1-weighted magnetic resonance ima-
ging of a 56-year-old female patient with sudden-onset 
numbness of the lower lip. The (A) pre-contrast and 
(B) post-contrast scans show an enhancing mass in 
the medial left mandibular ramus extending into the 
bone marrow through the mandibular canal. Coronal 
views at the level of (C) the mandibular ramus and 
(D) left mental nerve area show soft tissue enhanced 
signals near the left mandibular foramen (arrows).
 
Figure 2: Histopathology images of a plasmablastic myelo- 
ma in the oral mucosa. A: Haematoxylin and eosin stain 
at x40 magnification showing a diffuse cellular neoplastic 
infiltrate (white arrow) beneath the oral mucosa (black 
arrow). B: Haematoxylin and eosin stain at x600 magnifi-
cation displaying plasmablasts with scant cytoplasm, 
enlarged nuclei with vesicular chromatin and a single 
nucleolus and frequent mitosis (arrow) and apoptosis. 
C: 3,3'-Diaminobenzidine immunohistochemistry stain 
at x400 magnification indicating the immunoreactivity 
of the cells to cluster of differentiation (CD) 138. D: Stain 
showing the immunoreactivity of the neoplastic cells to 
CD138 with a Ki67 proliferation index of >90%.
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decreases the adhesion of plasma cells, resulting in 
the dissemination of plasma cells away from their 
original environment and into extramedullary sites.5 
In the current case, the plasma cells showed aggressive 
behaviour and diffuse neoplastic infiltration into the 
oral mucosa via histopathology. These cellular features, 
along with a loss of the CD138 marker, although this 
was not seen in the present case, generally result 
in a high-grade malignancy that responds poorly 
to treatment.5,8,17
Bladé et al. and Damaj et al. have reported that 
progression of MM into EMM is seen in 15–20% 
of patients, with an increased frequency in recent 
years.18,19 Relapsing EMM seems to exhibit aggressive 
behaviour since it manifests as a progression of the 
disease, leading to a poor prognosis despite various 
treatment modalities.17,19 In addition, survival follow-
ing an EMM relapse reportedly varies between 4–30 
months.20–22 In the current case, the patient responded 
poorly to treatment, developed new lesions at multiple 
sites and survived for only eight months following the 
diagnosis. Similar findings have been noted in previous 
reports.18,20–22 As such, a high index of suspicion is 
needed when treating patients with a previous history 
of MM, even during remission.
Conclusion 
Relapse of MM in the oral and maxillofacial region 
is rare. Dental and maxillofacial surgeons should 
have a high index of suspicion when treating patients 
with a previous history of neoplastic disease. Such 
patients should be evaluated by thorough clinical and 
radiographic examinations to determine the cause 
of any new symptoms developing, even if they are 
currently in remission.
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Discussion
MM is an uncommon haematological malignancy of 
the plasma cells which accounts for approximately 
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